Hepion Pharmaceuticals Inc (HEPA)

개요 뉴스 가격 이력 Financials 토론 예측 주식 분할

Relative Volume:

Hepion Pharmaceuticals Inc Stock (HEPA) Company Profile

Hepion Pharmaceuticals Inc

Healthcare (1065)

Biotechnology (594)

최신 SEC 제출 서류

HEPA's Discussions on Twitter

Compare HEPA vs VRTX, REGN, ARGX, MRNA, RVMD

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
HEPA Hepion Pharmaceuticals Inc	0.0769	0	0	-2.98M	-1.71M	-0.259
VRTX Vertex Pharmaceuticals Inc	508.34	130.64B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	784.85	80.46B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	990.32	61.58B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	154.04	57.48B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	190.95	43.68B	742.00K	-1.37B	-1.07B	-7.0731

Hepion Pharmaceuticals Inc Stock (HEPA) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2020-07-20	재개	ROTH Capital	Buy

Hepion Pharmaceuticals Inc 주식(HEPA)의 최신 뉴스

Hepion Pharmaceuticals Inc (HEPA) 재무 분석

Hepion Pharmaceuticals Inc (HEPA)

Hepion Pharmaceuticals Inc Stock (HEPA) Company Profile

Compare HEPA vs VRTX, REGN, ARGX, MRNA, RVMD

Hepion Pharmaceuticals Inc Stock (HEPA) Upgrades & Downgrades

Hepion Pharmaceuticals Inc 주식(HEPA)의 최신 뉴스

Insiders holding 51% of Hepion (HEPA) back reverse split and 750M-share increase - Stock Titan

Hepion (NASDAQ: HEPA) grants director 299,000 options at $0.08 - Stock Titan

Hepion Pharmaceuticals Secures Funding via Convertible Note Agreement - TipRanks

Hepion Pharmaceuticals Raises $500,000 Via 8% Secured Convertible Note With Gravitas, 12.5M Warrants - TradingView

Hepion Pharmaceuticals stock trades quietly as investors watch liver disease pipeline - ad-hoc-news.de

Major holders back Hepion (HEPA) reverse split, share increase - Stock Titan

Hepion Pharmaceuticals Inc. (HEPA) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research

Hepion Pharmaceuticals Announces New Private Placement Financing - TipRanks

Hepion Raises $400,000 in Private Placement at $0.05, Issues Five-Year Warrants at $0.06 - TradingView

Hepion Pharmaceuticals Inc. (HEPA) Peer Comparison – Compare with Others - Value Research

CTRVP SEC FilingsHepion Pharmaceuticals, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan

Hepion (HEPA) grants interim CEO 1.35M options at $0.08 - Stock Titan

Hepion chair granted 1.35M options at $0.08 | HEPA Insider Trading - Stock Titan

Hepion Pharmaceuticals (HEPA) gives VP 1.35M options at $0.08 - Stock Titan

Hepion (HEPA) director awarded 299K stock options - Stock Titan

Hepion Pharmaceuticals (HEPA) awards director 299K stock options - Stock Titan

Hepion Pharmaceuticals (HEPA) awards 299K options to director - Stock Titan

Hepion Pharmaceuticals Appoints James Liddy to Board of Directors - Minichart

Hepion appoints James Liddy to its board - TradingView

Hepion (NASDAQ: HEPA) COO locks in 2M warrants at $0.06 - Stock Titan

Hepion (HEPA) chairman-led group builds 26M-share stake - Stock Titan

Black Global 5 Llc Net Worth (2026) - GuruFocus

Wednesday’s insider buys and sells: Hepion insiders invest $800K By Investing.com - Investing.com Nigeria

Hepion Pharmaceuticals, Inc. Q2 2026: Revenue $0 Net loss $(1.25M), EPS $(0.08) — 10-Q Summary - TradingView

Hepion Pharmaceuticals director Stetz buys $25,000 in common stock By Investing.com - Investing.com Nigeria

Hepion Pharmaceuticals interim CEO Gary Stetz buys $100,000 in stock By Investing.com - Investing.com Nigeria

Hepion Pharmaceuticals director Michael Purcell buys $100,000 in stock By Investing.com - Investing.com Australia

Hepion Pharmaceuticals director Stetz buys $25,000 in common stock - Investing.com

Hepion Pharmaceuticals interim CEO Gary Stetz buys $100,000 in stock - Investing.com

Hepion COO Sireesh Appajosyula buys $100,000 in common stock By Investing.com - Investing.com Nigeria

Hepion COO Sireesh Appajosyula buys $100,000 in common stock - Investing.com

Hepion Pharmaceuticals executive chairman LoPriore buys $500,000 in stock - Investing.com

Hepion Pharmaceuticals executive chairman LoPriore buys $500,000 in stock By Investing.com - Investing.com India

Hepion Pharmaceuticals (HEPA) director purchases 500K shares and 500K warrants - Stock Titan

Hepion Pharmaceuticals (NASDAQ: HEPA) director purchases 2M shares and 2M warrants - Stock Titan

Hepion Pharmaceuticals (HEPA) interim CEO Stetz buys 4M shares and warrants - Stock Titan

Hepion Pharmaceuticals (HEPA) chair LoPriore reports 20M-share and warrant purchases - Stock Titan

Hepion Pharmaceuticals (HEPA) holder reports 10M warrants and 10M shares - Stock Titan

Darin Feinstein Discloses Investment at Hepion Pharmaceuticals with 11.1% Stake - TradingView

Investor buys 10M Hepion Pharmaceuticals (HEPA) shares plus warrant - Stock Titan

Hepion Pharmaceuticals (HEPA) completes $3.06M exempt securities sale under Rule 506(b) - stocktitan.net

Hepion Pharmaceuticals, Inc. announced that it has received $3.055 million in funding - marketscreener.com

Hepion Pharmaceuticals, Inc. Revenue Breakdown – OTC:HEPA - TradingView

Hepion Pharmaceuticals, Inc. Revenue Breakdown – OTC:CTRVP - TradingView

Hepion Pharmaceuticals (HEPA) Proxy Filing Summary - Quartr

Hepion Pharmaceuticals (HEPA) Proxy filing Summary - Quartr

Hepion Pharmaceuticals (HEPA) Q4 2025 earnings summary - Quartr

Hepion Pharmaceuticals (HEPA) director Stetz submits initial insider Form 3 - Stock Titan

Hepion Pharmaceuticals (HEPA) director Danina Fisher files initial Form 3 - Stock Titan

Hepion Pharmaceuticals Inc (HEPA) 재무 분석

매출

순이익

현금흐름

주당 순 이익

HEPA과 유사한 종목